In psoriasis, the persistent activation of TLRs, particularly TLR2 and TLR4, along with sustained NF-κB signaling, drives chronic inflammation and promotes the differentiation and expansion of pathogenic Th1 and Th17 cells [37,38]. This evidence concerns the gene NFKB1 and psoriasis.